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Abstract
Background: Migrants are considered a key population at risk for sexually transmitted and blood-borne diseases in
Europe. Prevalence data to support the design of infectious diseases screening protocols are scarce. We aimed to
estimate the prevalence of hepatitis B and C, human immunodefiency virus (HIV) infection and syphilis in specific
migrant groups in Finland and to assess risk factors for missed diagnosis.
Methods: A random sample of 3000 Kurdish, Russian, or Somali origin migrants in Finland was invited to a migrant
population-based health interview and examination survey during 2010–2012. Participants in the health
examination were offered screening for hepatitis B and C, HIV and syphilis. Notification prevalence in the National
Infectious Diseases Register (NIDR) was compared between participants and non-participants to assess non-
participation. Missed diagnosis was defined as test-positive case in the survey without previous notification in NIDR.
Inverse probability weighting was used to correct for non-participation.
Results: Altogether 1000 migrants were screened for infectious diseases. No difference in the notification
prevalence among participants and non-participants was observed. Seroprevalence of hepatitis B surface antigen
(HBsAg) was 2.3%, hepatitis C antibodies 1.7%, and Treponema pallidum antibodies 1.3%. No cases of HIV were
identified. Of all test-positive cases, 61% (34/56) had no previous notification in NIDR. 48% of HBsAg, 62.5% of anti-
HCV and 84.6% of anti-Trpa positive cases had been missed. Among the Somali population (n = 261), prevalence of
missed hepatitis B diagnosis was 3.0%. Of the 324 Russian migrants, 3.0% had not been previously diagnosed with
hepatitis C and 2.4% had a missed syphilis diagnosis. In multivariable regression model missed diagnosis was
associated with migrant origin, living alone, poor self-perceived health, daily smoking, and previous diagnosis of
another blood-borne infection.
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Conclusions: More than half of chronic hepatitis and syphilis diagnoses had been missed among migrants in
Finland. Undiagnosed hepatitis B among Somali migrants implies post-migration transmission that could be
prevented by enhanced screening and vaccinations. Rate of missed diagnoses among Russian migrants supports
implementation of targeted hepatitis and syphilis screening upon arrival and also in later health care contacts.
Coverage and up-take of current screening among migrants should be evaluated.
Keywords: Migrant, Hiv, Hepatitis B, Hepatitis C, Syphilis, Screening, Prevalence, Population-based study, Non-
participation, Missed diagnosis
Background
Migrants are considered to be especially vulnerable to
infectious diseases due to infection epidemiology and
conditions in the countries of origin and transit, and be-
havioural factors and other vulnerabilities [1]. Infectious
disease screening upon immigration is one of the most
prevalent strategies adopted to address the increased risk
for infection [2]. However, recent reports describe con-
siderable post-immigration acquisition of infections, es-
pecially human immunodeficiency virus (HIV) [1, 3].
In Finland, 90% of chronic hepatitis B, 14% of hepatitis
C, 60% of HIV and 58% of syphilis cases were diagnosed
among individuals of foreign origin in 2016 [4]. Since
1990, refugees and asylum seekers to Finland have been
offered screening for pulmonary tuberculosis, HIV, hepa-
titis B, and syphilis on arrival [5]. Screening for hepatitis
C is not included in the national screening protocol. In
2010, 4.4% (n = 237,066) of the Finnish population had
foreign origin and were born abroad [6]. The largest mi-
grant group had Russian origin (23.9%). Somali (n =
8368) and Kurdish origin (n = 8032) migrants repre-
sented the major migrant populations with refugee back-
ground in Finland in 2010.
Due to insufficient information on the prevalence of in-
fectious diseases among migrants in Finland, the current
screening recommendations are based on the epidemi-
ology of the infectious diseases in the countries of origin
[7]. Here, we aimed to assess the prevalence, burden of
disease and risk factors for a missed diagnosis of hepatitis
B and C, HIV and syphilis in a migrant population-based
study validated by a non-participation analysis.
Methods
The migrant population-based health interview and
examination survey (Maamu) examined the health of
Kurdish, Russian, and Somali origin migrants in Finland
in 2010–2012 [8]. The inclusion criteria for the cross-
sectional health interview and examination survey were
Kurdish, Russian, or Somali origin, age 18 to 64 years,
and having lived in Finland for a minimum of one year.
Kurdish origin was defined as speaking Kurdish as the
mother tongue and born in Iran or Iraq. Russian origin
was defined as speaking Russian or Finnish as the
mother tongue and born in Russia or the former Soviet
Union (FSU). Individuals born in Somalia were defined
as having Somali origin.
A random sample of 3000 migrants, stratified by study
location and ethnicity, was drawn from the Population
Information System (PIS). All residents in Finland are
registered to the Finnish PIS and given a unique Per-
sonal Identity Code (PIC). Temporary residents, such as
travelers or asylum seekers, are registered a temporarory
PIC while accessing public services. After receiving resi-
dency, a temporary PIC is replaced by a permanent PIC
in electronic health records or national registers.
One thousand migrants from each ethnic group were
invited to participate in a health interview followed by a
health examination (Fig. 1). Those who refused the 281-
item standard protocol were offered the possibility to par-
ticipate in a short interview containing only the most rele-
vant 62 questions, or in health examination only. During
the health interview the participants were questioned
about previous history of infectious diseases and participa-
tion in screening for infectious diseases upon arrival to
Finland, among other socio-demographic determinants,
including mental health symptoms [9]. Participants pro-
vided a written informed consent separately for participa-
tion in the health interview, examination, and testing.
Screening tests were offered during the health examin-
ation. Hepatitis B surface antigen (HBsAg) was tested
with Abbot ARCHITECT® HBsAg (Abbot, Chigago, Illi-
nois,USA) and confirmed with Abbot AXSYM® Con-
firmatory. Hepatitis C antibodies (anti-HCV) were tested
with Abbot ARCHITECT® Anti-HCV and confirmed
with Fujirebio INNOTEST® HCV Ab (Fujirebio, Mal-
vern, Pennsylvania, USA). Serum HIV antigen and anti-
bodies (HIVAgAb) were tested with Abbot
ARCHITECT® HIV Ag/Ab Combo and confirmed with
Fujirebio INNO-LIA® HIV. Treponema pallidum specific
antibodies (anti-Trpa) were tested with Abbot ARCHI-
TECT® TP and confirmed with Fujirebio INNO-LIA®
Syphilis. The laboratory analyses were performed in the
National Institute for Health and Welfare (THL) [10].
Anti-HCV seropositivity was confirmed in HUSLAB
(Helsinki, Finland). All those who participated in testing
were informed about the results. Negative results were
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sent in mailed letters and positive findings were commu-
nicated by a study physician who also referred the pa-
tients for follow-up.
The National Infectious Diseases Register (NIDR) was
established on 1 January 1995. Both physicians and la-
boratories are obliged by the Communicable Disease Act
to report specific diagnoses and microbiological findings
to the NIDR. Their reporting is independent of each
other. We linked the Maamu sample to the NIDR using
the PICs and retrieved notifications for HIV, hepatitis B
and C, and syphilis that were made before the launch of
the Maamu study on 1 January 2010. For the analysis,
we excluded those migrants who had immigrated to
Finland before January 1995 and who could have had a
diagnosis without notification to the NIDR. To evaluate
the impact of non-participation, we compared the notifi-
cation prevalence in the NIDR between participants and
non-participants during 1 January 1995 and 31 Decem-
ber 2009. Register linkage did not require a consent
from the non-participants. A case testing positive in the
Maamu study, but without previous notification to the
NIDR was considered a “missed” diagnosis.
Statistical methods
IBM SPSS Statistics 24 (Microsoft), including a Complex
Samples module, was used for the statistical analysis.
The multiple choice variables were recoded into two cat-
egories. Non-participation was addressed by calculating
inverse probability weights for all participants [8, 11].
Factors associating with participation were assessed with
logistic regression and, based on Bayeasian Information
Criterion, age group, sex, migrant group, municipality,
and marital status were chosen as auxiliary variables in
the weight calculation. Separate weights were developed
for participation in different stages of the study: the
health interview with the standard or short protocol, or
in the health examination. Non-participants were
assigned a zero weight.. Null hypothesis was tested using
Wald’s F-test and p-values below 0.05 were considered
significant. For the multivariable logistic regression, vari-
ables with a univariate p below 0.2 were included. The
interactions between variables in the multivariate model
were tested. All individuals who participated in testing
were included in the multivariable model. The odds ra-
tios (ORs) for continuous variables were calculated for
every one year increase.
Results
Basic characteristics
Altogether 1843 individuals, representing 61.4% of the
sample, participated in the Maamu study (Fig. 1). Of
these, 423 participants had immigrated before 1 January
Health examination, n=1071
445 (70.7%) Kurdish
347 (49.4%) Russian
279 (54.5%) Somali
Random sample from the 
population register, n=3000
1000 Kurdish
1000 Russian
1000 Somali
Health interview with 
standard protocol, n= 1098
430 (68.3%) Kurdish
404 (57.5%) Russian
264 (51.6%) Somali
Health interview with short
protocol, n=295
93 (14.8%) Kurdish
110 (15.7%) Russian
92 (18.0%) Somali
Blood testing, n=1000
415 (93.3%) Kurdish
324 (93.4%) Russian
261 93.5%) Somali
Participated to the study partly or
completely, n=1843
629 (62.9%) Kurdish
702 (70.2%) Russian
512 (51.2%) Somali
Did not participate to the study, 
n=1157
371 (37.1 %) Kurdish
298 (29.8 %) Russian
488 (48.8 %) Somali
Year of immigration
before 1995, n=423
94 Kurdish
187 Russian
142 Somali
Year of immigration
before 1995, n=404
91 Kurdish
104 Russian
209 Somali
Linkage to National Infectious Disease Register
Refused blood
testing, n=71
30 (6.7%) Kurdish
23 (6.6%) Russian
18 (6.5%) Somali
Refused health
examination, n=350
91 (14.5%) Kurdish
168 (23.9%) Russian
91 (17.8%) Somali
Fig. 1 Study participation
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1995 and were excluded from the analysis. The overall
participation in the study was highest among Russian
migrants, but a large proportion of these individuals had
moved to Finland before 1995. The study population
comprised 1000 participants who were tested for an in-
fectious disease. The non-participants to the study and
the individuals who refused the health examination or
the blood testing were considered non-participants in
the analysis.
The overall acceptability of testing did not differ be-
tween Kurdish, Russian, or Somali participants (93.3%,
93.4%, and 93.5%, respectively, p = 0.988). HIVAgAb test
was accepted by 91.7% of the participants to the health
examination without a difference between the migrant
groups (p = 0.433). There was also no difference in the
acceptability of HBsAg and anti-HCV tests (93.2%, p =
0.997) or the anti-Trpa test (92.3%, p = 0.825) among
participants of different origin.
Migrants from Somalia were significantly younger
(mean 32.4 years) than Kurdish (34.9 years) or Russian
(38.6 years) migrants (Table 1). In general, men were
younger (mean 34.5 years) than women (mean 36.4 years)
(p = 0.027) and men had lived in the country for a
shorter period (mean 8.7 years) than women (mean
9.4 years) (p < 0.001). Russian migrants were older at im-
migration (mean 29.6 years) than Kurdish (25.5 years) or
Somali (23.6 years) migrants. Twice as many Somali im-
migrants had arrived to Finland before the age of
18 years relative to Kurdish or Russian migrants. Two
thirds (67.2%) lived in the capital area. Especially Kurd-
ish and Somali men had received their residency permit
as refugees or due to international protection of asylum
seekers.
Russian immigrants had higher education than mi-
grants of Kurdish or Somali origin and were more often
employed. However, no difference in self-perceived liter-
acy in Finnish or Swedish was observed. Somali women
had significantly less tertiary education than men (11.3%
vs. 30.7%, p = 0.002) and had poorer literacy skills (77.9%
vs. 93.4%, p = 0.004).
Somali migrants perceived their health as significantly
better than Kurdish or Russian participants and reported
less long-term illnesses. Migrant women in general re-
ported less often a good health status than men (66.6%
vs. 78.3%, p < 0.001) and reported more chronic illnesses
(33.9% vs. 23.0%, p < 0.001). Psychiatric symptoms were
reported especially by Kurdish women.
Health behaviours
Important differences emerged in health behaviours and
health care seeking practices between the migrant
groups (Table 2). Somali migrants did not report any al-
cohol consumption during the past year. Among Kurd-
ish migrants, a significantly smaller proportion of
women than men had used alcohol within the last year
(p < 0.001). Smoking was significantly more common
among migrant men (25.0%) than women (4.1%, p <
0.001). Only two participants reported previous use of
injectable drugs.
Migrants from Somalia had visited a doctor during the
last year or participated in a health check-up during the
last five years significantly less often than Kurdish or
Russian migrants (p = 0.002 and < 0.001, respectively).
More Russian women reported visiting a doctor within
the past year (75.4% vs. 59.1%) and participating in
health check-ups during the last five years (87.1% vs.
67.1%) than Russian men (p = 0.007 and < 0.001, respect-
ively). Somali women had significantly less abortions
than Kurdish or Russian migrants.
Post-migration travelling to the former country of ori-
gin was especially prevalent among Kurdish and Russian
migrants. Men reported more travelling than women
(68.0% vs. 57.8%, p = 0.003). As a reflection of the migra-
tion background, Kurdish and Somali origin migrants re-
ported more often participation in infectious disease
screening upon arrival to Finland. Somali migrants re-
ported more often a previous diagnosis of a blood-borne
infection.
Non-participation
Notification prevalence in the NIDR between 1 January
1995 and 31 December 2009 did not differ between par-
ticipants and non-participants with respect to hepatitis B
or C or syphilis (p = 0.387, 0.992, and 0.586, respect-
ively). No previous notifications of HIV were identified
among the participants or among the non-participants
to the testing.
Seroprevalence and missed diagnosis
The overall HBsAg seroprevalence was 2.3% [95% CI
1.5–3.5%], the seroprevalence of anti-HCV was 1.7%
[1.0–2.9%], and the seropositivity of anti-Trpa was 1.3%
[0.7–2.3%]. No HIVAgAb-positive cases were identified.
Significant differences in disease prevalence were ob-
served between and within migrant groups (Table 3).
Seropositivity to HBsAg was highest among the Somali
migrant population, whereas anti-HCV and Trpa-Ab
were most prevalent among the Russian migrant popula-
tion. Among subjects of Russian origin, women had a
significantly higher rate of anti-Trpa positivity than men
(p = 0.044). None of the Kurdish women tested positive
for HBsAg, anti-HCV or anti-Trpa.
The infectious disease prevalence increased consist-
ently with age. The youngest age cohort (18–29 years)
had an HBsAg prevalence of 1.8% [95% CI 0.8–4.0%],
the 30- to 44-year-olds 2.1% [1.0–4.3%], and the 45- to
64-year-olds 3.4% [1.7–6.5%]. A similar observation was
made for anti-HCV seroprevalence (0.7% [0.2–3.0%]
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among the youngest, 1.5% [0.6–3.8%] among the middle
group, and 3.5% [1.8–6.8%] among the oldest group) and
for anti-Trpa seroprevalence (0.4% [0.1–2.1%] among
the youngest, 1.2% [0.4–3.2%] among the middle group,
and 3.1% [1.5–6.4%] among the oldest group).
Altogether 60.7% (n = 34) of the laboratory diagnoses
made in the Maamu study had no previous notification
in the NIDR and were considered missed diagnoses
(Fig. 2). These 34 missed laboratory diagnoses were
identified in 33 individuals. The majority of the anti-
HCV (62.5%, n = 10) and anti-Trpa (84.6%, n = 11) find-
ings had no previous notification in the NIDR, whereas
for HBsAg 48.1% (n = 13) had not been diagnosed earl-
ier. Of the previously made diagnoses, 50.0% were noti-
fied within a year of the immigration.
The highest number of missed diagnoses was observed
among Russian migrants, 5.9% (n = 18) of whom were
diagnosed with a previously unnotified infectious dis-
ease. Of these, 3 cases tested positive for HBsAg, 7 cases
for anti-HCV, and 7 cases for anti-Trpa. One case tested
positive for both anti-HCV and anti-Trpa. Of the Somali
migrants, 4.1% (n = 11) tested positive for a previously
unnotified infectious disease. Of these, 8 cases tested
positive for HBsAg, 1 case for anti-HCV, and 2 cases for
anti-Trpa. The Kurdish migrants had the lowest number
of missed diagnoses (0.9%, n = 4). Of these, 2 were
HBsAg, 1 anti-HCV, and 1 anti-Trpa. Eight cases with a
missed diagnosis reported that they had been previously
diagnosed with a blood-borne infection and six of them
named the disease correctly.
Table 1 Population weighteda basic characteristics of the the study population; % (crude n)
Characteristic Total; n = 1000 Men; n = 447 Women; n = 553
Kurdish;
n = 415
Russian;
n = 324
Somali;
n = 216
p Kurdish;
n = 225
Russian;
n = 119
Somali;
n = 103
p Kurdish;
n = 190
Russian;
n = 205
Somali;
n = 261
p
Age
18–29 years
30–44 years
45–64 years
34.1
(141)
47.2
(193)
18.7 (81)
29.1 (92)
34.1
(111)
36.8
(121)
46.0
(123)
37.0 (85)
16.9 (53)
<
0.001
36.1 (81)
46.2
(102)
17.7 (42)
31.7 (35)
39.5 (47)
28.8 (37)
53.5 (59)
31.4 (28)
15.1 (16)
0.009 31.6 (60)
48.4 (91)
20.0 (39)
27.5 (57)
30.7 (64)
41.8 (84)
41.4 (64)
40.5 (57)
18.1 (37)
<
0.001
Age at immigration
Below 18 years
18 to 30 years
31 years or more
18.5 (84)
51.0
(204)
30.5
(127)
19.2 (60)
35.0
(111)
45.8
(153)
36.4
(106)
39.5 (87)
24.1 (68)
<
0.001
16.9 (47)
53.5
(111)
29.7 (67)
28.3 (32)
30.0 (34)
41.7 (53)
45.3 (52)
32.0 (29)
22.7 (22)
<
0.001
20.6 (37)
47.9 (93)
31.5 (60)
13.6 (28)
38.1 (77)
48.3
(100)
30.9 (54)
44.2 (58)
24.9 (46)
<
0.001
Time of residency in
Finland
Less than 5 years
5–10 years
11 years or more
23.2 (97)
36.9
(145)
39.8
(160)
29.4 (98)
29.5 (93)
41.1
(128)
31.6 (95)
32.7 (75)
35.6 (76)
0.079 24.5 (55)
40.7 (84)
34.9 (74)
27.1 (35)
35.1 (39)
37.8 (42)
34.4 (41)
41.6 (33)
24.0 (22)
0.264 21.7 (42)
32.3 (61)
46.0 (86)
30.8 (63)
26.1 (54)
43.1 (86)
29.9 (54)
27.2 (42)
42.9 (54)
0.280
Living in the Helsinki
metropolitan area
47.4
(189)
79.9
(204)
83.8
(153)
<
0.001
45.1 (91) 79.4 (72) 78.5 (51) <
0.001
50.3 (98) 80.3
(132)
87.0
(102)
<
0.001
Immigration as an asylum
seeker or refugee
73.2
(277)
1.2 (3) 72.0
(151)
<
0.001
85.2
(171)
1.7 (2) 93.5 (75) <
0.001
58.8
(106)
0.9 (1) 56.7 (76) <
0.001
Married, registered
relationship or co-
habitation
66.4
(278)
58.5
(200)
66.2
(161)
0.089 63.5
(140)
56.5 (71) 58.3 (55) 0.465 70.0
(138)
59.7
(129)
71.1
(106)
0.060
Secondary education or
moreb
41.7
(162)
78.5
(249)
18.8 (36) <
0.001
42.3 (86) 72.6 (82) 30.7 (22) <
0.001
41.0 (76) 82.2
(167)
11.3 (14) <
0.001
Employed, full or part-time 37.7
(147)
47.8
(152)
16.1 (36) <
0.001
44.7 (93) 53.3 (61) 20.7 (19) <
0.001
28.9 (54) 44.3 (91) 13.2 (17) <
0.001
Able to read well in
Finnish/ Swedishc
83.5
(308)
83.7
(252)
85.0
(154)
0.893 85.3
(167)
83.9 (89) 93.4 (77) 0.112 81.2
(141)
83.5
(163)
77.9 (77) 0.529
Experienced violence
during the last 12 month
6.5 (Z7) 1.2 (4) 3.9 (8) 0.006 6.5 (12) 1.2 (1) 0 (0) 0.007 6.4 (15) 1.1 (3) 6.7 (8) 0.014
Bolded p-values represent statistically significant differences between the migrant groups
aPopulation weights developed according to age group, sex, migrant population, municipality and marital status
bHighschool, professionnal school or similar
cTwo categories of a 4 gategory Likert scale combined: moderate or good reading skills
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Table 2 Population weighteda health status and health behaviours of the study population; % (crude n)
Characteristics Total; n = 1000 Men; n = 447 Women; n = 553
Kurdish;
n = 415
Russian;
n = 324
Somali;
n = 216
p Kurdish;
n = 225
Russian;
n = 119
Somali;
n = 103
p Kurdish;
n = 190
Russian;
n = 205
Somali;
n = 261
p
Long term illness 31.5
(123)
35.3
(114)
16.1
(35)
<
0.001
28.9 (58) 23.1 (29) 8.3 (8) 0.003 34.6 (65) 42.8 (85) 21.0
(27)
0.001
Self-perceived good health 68.1
(271)
66.4
(206)
85.9
(212)
<
0.001
72.7
(156)
77.4 (85) 93.2
(89)
0.003 62.5
(115)
59.5
(121)
81.3
(123)
<
0.001
Mental health symptomsb 34.4
(138)
15.7 (50) 10.2
(28)
<
0.001
22.6 (45) 8.8 (10) 7.0 (8) 0.001 48.8 (93) 19.9 (40) 12.1
(20)
<
0.001
At least one previous delivery
(women)
NA NA NA NA NA NA NA NA 78.8
(145)
71.5
(142)
78.7
(96)
0.247
At least one previous abortion
(women)
NA NA NA NA NA NA NA NA 22.4 (39) 55.8
(106)
1.3 (4) <
0.001
Alcohol consumption during the
last 12 months
37.0
(143)
87.1
(277)
0 (0) NA 53.2
(110)
87.6
(100)
0 (0) NA 17.1 (33) 86.8
(177)
0 (0) NA
High alcohol consuption (AUDIT-C)c 1.0 (6) 3.2 (10) 0 (0) NAd 1.9 (6) 5.2 (8) 0 (0) NA 0 (0) 2.0 (2) 0 (0) NAd
Smokes daily 18.2 (71) 16.3 (50) 2.1 (9) <
0.001
30.5 (64) 29.6 (33) 5.4 (9) <
0.001
3.2 (7) 8.1 (17) 0 (0) NAd
History of injecting drugs 0.2 (1) 0.3 (1) 0 NA 0.4 (1) 0.7 (1) 0 (0) 0.628 0 (0) 0 (0) 0 (0) NA
Visited a doctor during the last
12 months
70.3
(283)
69.1
(224)
56.3
(131)
0.002 67.4
(143)
59.1 (73) 52.7
(46)
0.059 73.8
(140)
75.4
(151)
58.6
(85)
0.005
Health check-up during the past
5 years
72.6
(266)
79.2
(246)
59.9
(114)
<
0.001
68.8
(131)
67.1 (79) 63.7
(50)
0.734 77.2
(135)
87.1
(167)
56.9
(64)
<
0.001
Healthcare visit due to a mental
health problem during the last
12 months
11.7 (49) 4.1 (16) 1.7 (4) <
0.001
5.5 (10) 5.8 (7) 0.6 (1) 0.056 19.2 (39) 3.0 (9) 2.4 (3) <
0.001
Participation to infectious diseases
screening upon arrival to Finland
84.9
(324)
13.8 (61) 80.9
(172)
<
0.001
85.7
(173)
17.8 (30) 84.4
(72)
<
0.001
84.0
(151)
11.3 (31) 78.4
(100)
<
0.001
Post-migration travelling to country
of origin
59.6
(229)
97.5
(300)
15.7
(36)
<
0.001
53.4
(106)
98.6
(110)
9.1 (10) <
0.001
67.2
(123)
96.8
(190)
20.6
(26)
<
0.001
Previos diagnosis of a blood borne
infection
0.6 (2) 4.6 (15) 14.4
(36)
<
0.001
0.7 (1) 5.3 (6) 12.8
(14)
0.004 0.6 (1) 4.1 (9) 15.5
(22)
<
0.001
Bolded p-values represent statistically significant differences between the migrant groups
NA Not available
aPopulation weights developed according to age group, sex, migrant population, municipality and marital status
bHopkins Sympton Checklist-25 (HSCL-25) score over 1.75
cAUDIT-C is a validated, three question tool to screen unhealthy alcohol use. Positive score for 7 points or more
dA quasi-complete segregation in the data. The maximum likelihood estimation does not exist
Table 3 Population weighteda prevalence of infectious diseases among the study population; % [95% Confidence Interval] (crude n).
Total n = 1000
Kurdish; n = 415 Russian; n = 324 Somali; n = 261 p
n % (95% CI) n % (95% CI) n % (95% CI)
HIVAgAb; n = 982 0 0 0 0 0 0 NA
HBsAg; n = 996 2 0.4 (0.1–1.5) 5 1.7 (0.7–4.3) 16 6.0 (3.6–9.9) < 0.001
anti-HCV; n = 996 1 0.1 (0.0–0.5) 12 4.1 (2.2–7.3) 3 1.3 (0.4–4.1) < 0.001
anti-Trpa; n = 988 1 0.3 (0.1–1.9) 9 2.9 (1.5–5.6) 2 1.0 (0.2–3.8) 0.042
Bolded p-values represent statistically significant differences between the migrant populations
NA Not available
aPopulation weights developed according to age group, sex, migrant population, municipality and marital status
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Missed diagnosis was associated with living alone, self-
perceived poor health, smoking cigarettes, and self-
reported previous diagnosis of a blood-borne infection
(Table 4). A significant interaction was observed be-
tween origin and marital status, as married Somali origin
migrants had a significantly lower risk for a missed diag-
nosis than Somali origin migrants who lived alone.
Additionally, in univariate analysis, missed diagnosis was
associated with Somali or Russian origin, older age at
time of study and time of immigration, no self-reported
long-term illness, history of injecting drug use (OR
27.728, 95% CI 1.94–395.50), consumption of alcohol
during the last 12 months (OR 2.98, 95% CI 1.29–6.90),
and for women, having had at least one previous
9
2 0
11
5
4 2
11
13
10
11
34
0
5
10
15
20
25
30
35
40
HBsAg Anti-HCV Anti-Trpa Total
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Fig. 2 Delay from immigration to diagnosis among the study population; n = 1000
Table 4 Risk factors for a missed HBsAg, anti-HCV or anti-Trpa diagnosis
Variable Missed diagnosis; %a (nb) Univariable p Missed diagnosis; OR (95% CI) Multivariable p Missed diagnosis; aOR (95% CI)
Origin
Kurdish
Russian
Somali
0.9 (4)
5.9 (18)
4.1 (11)
0.001 1
7.36 (2.51–21.60)
5.26 (1.66–16.65)
NA 1
7.74 (1.55–38.75)
1.52 (0.18–13.10)
Agec
18-29 years
30–44 years
45–64 years
1.2 (6)
2.9 (9)
7.2 (18)
< 0.001 1.06 (1.03–1.09) 0.816 0.989 (0.90–1.07)
Age at immigrationc
Below 18 years
18 to 30 years
31 years or more
2.1 (8)
1.2 (4)
6.9 (21)
< 0.001 1.05 (1.02–1.09) 0.214 1.061 (0.97–1.16)
Married, registered
relationship or co-
habitation
Kurdish
Russian
Somali
0.6 (2)
8.6 (11)
6.8 (3)
0.393
0.734
0.012
0.43 (0.06–3.01)
1.19 (0.43–3.32)
0.15 (0.03–0.65)
0.001 0.37 (0.05–2.65)
1.05 (0.34–3.22)
0.05 (0.01–0.36)
Long term illness 5.4 (13) 0.044 0.46 (0.22–0.98) 0.861 0.91 (0.32–2.58)
Perceived good health 2.1 (15) 0.003 0.32 (0.15–0.67) 0.064 0.34 (0.11–1.06)
Smokes daily 6.8 (9) 0.025 2.57 (1.13–5.87) 0.003 3.71 (1.59–8.68)
Previos diagnosis of a
blood borne infection
13.9 (8) < 0.001 5.78 (2.30–14.50) 0.004 9.00 (2.05–39.44)
Bolded p-values represent statistically significant differences in prevalence of missed diagnosis
aWeighted prevalence, Population weights developed according to age group, sex, migrant population, municipality and marital status
bCrude n
cVariable used as a continuous variable in the univariate and multivariate analysis
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abortion (OR 3.23, 95% CI 1.11–9.53). Due to quasi-
complete separation in the data, history of previous
injecting drug use, alcohol consumption within the last
12 months and at least one previous abortion were ex-
cluded from the multivariable analysis.
Burden of infections
Based on the number of first-generation migrants in
Finland in 2016 [6], we extrapolated the number of
missed hepatitis B or C or syphilis diagnoses among the
20- to 64-year-old migrant populations (Table 5). The
largest burden of missed infections was estimated among
the Russian migrant population, with altogether 3538
missed hepatitis B or C or syphilis diagnoses.
Discussion
To our knowledge, the Maamu study was the first mi-
grant population-based study to assess the prevalence of
HIV, hepatitis B and C, and syphilis and associated risk
factors among unselected migrant populations. The ma-
jority of the infections identified in the study had not
been previously notified and were hence considered
“missed”. Findings from the non-participation analysis
imply that the results from the study are generalizable to
the total migrant populations. Population-based observa-
tions of infectious disease prevalence among unselected
migrant populations are scarce [12, 13], as many studies
have recruited migrants with presumably higher baseline
risk for infection, e.g. from health care settings or with
limited access to services [14].
The infection profile differed significantly between
Kurdish, Russian, and Somali migrant populations. The
highest HBsAg prevalence was identified among Somali
migrants, whereas the highest prevalences of hepatitis C
and syphilis were observed among Russian migrants.
Kurdish migrants had low levels of infections. The iden-
tified hepatitis B/C seroprevalence rates were in general
comparable [13, 15] or lower [16] than those reported in
previous literature among migrants to high-income
countries [17]. Similarly was the prevalence lower or
comparable than among the general population in the
countries of origin. Hepatitis B seroprevalence in Iran
has been estimated at 2.8–3.7%, in Russia and FSU 2.3–
5.6% and in Somalia 9.1–19.8% [18]. A modelling study
estimated the prevalence of chronic viremic hepatitis C
in Iran and Iraq at 0.2–0.3% and in Russia at 2.3–3.5%
[19]. Hepatitis C antibody prevalence in Somalia has
been estimated at 0.3–1.9% [20].
Syphilis is considered not to disproportionately infect
migrants in the European region [1]. Only a minority of
the European countries, including Finland, have included
syphilis in the national screening recommendations [2,
5]. Our results demonstrate noteable syphilis prevalence
among unselected Russian and Somali migrant popula-
tions, with the majority of syphilis infections remaining
undiagnosed. The findings suggest that migrants have
vulnerabilities to syphilis and support the inclusion of
syphilis in the national screening protocols.
No cases of HIV were observed in our study, which
can be explained by selection of migrants originating
from low prevalence settings [21]; the HIV prevalence
among adults in Somalia has been estimated at 0.2–0.5%
and in Iran at < 0.1–0.2% in 2016 [22]. Estimates of the
HIV prevalence in the general population in Russia are
scarce as studies tend to assess key populations at risk
for HIV [23]. HIV prevalence among adults in the region
has been estimated at 0.8–1.0% [24]. Concentration of
the epidemic to people who inject drugs and prisoners
might explain the observed low prevalence of HIV
among Russian origin migrants in Finland.
Table 5 Estimated burden of missed hepatitis B/C and syphilis diagnoses among 20–64 year old migrant populations in Finland
Kurdisha Russianb Somali
Migrant population in Finlanda; aged 20 to 64 years; n 17,000 58,000 9000
Migrant population tested in Maamu; n 415 324 261
Hepatitis B
Prevalence of missed HBsAg diagnosis in Maamu; %c [95% CI] (nd) 0.4 [0.1–1.5] (2) 0.7 [0.2–2.2] (3) 3.0 [1.4–6.1] (8)
Number of missed HBsAg diagnosis in the population; n [95% CI] 68 [17–255] 406 [116–1276] 270 [126–549]
Hepatitis C
Prevalence of missed anti-HCV diagnosis in Maamu; %c [95% CI] (nd) 0.1 [0.0–0.5] (1) 3.0 [1.5–5.9] (8) 0.3 [0.0–1.9] (1)
Number of missed anti-HCV diagnosis in the population; n [95% CI] 17 [0–85] 1740 [870–3422] 27 [0–171]
Syphilis
Prevalence of missed anti-Trpa diagnosis in Maamu; %c [95% CI] (nd) 0.3 [0.1–1.9] (1) 2.4 [1.2–4.9] (8) 1.0 [0.2–3.8] (2)
Number of missed anti-Trpa diagnosis in the population; n [95% CI] 51 [17–323] 1392 [696–2842] 90 [18–342]
aFirst generation immigrants with a country of origin Iraq or Islamic Republic of Iran
bFirst generation immigrants with a country of origin Russia or Former Soviet Union
cWeighted prevalence. Population weights developed according to age group, sex, migrant population, municipality and marital status
dCrude n
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Seroprevalence of HBsAg, anti-HCV, and anti-Trpa in-
creased consistently with age in all migrant populations,
in line with earlier studies [16]. Missed diagnosis was as-
sociated with older age at testing and older age at immi-
gration in the univariate analysis. Older age at migration
results in a prolonged exposure time in high prevalence
settings. In our study, Russian origin migrants had im-
migrated to Finland at a significantly older age, and
hence, their exposure time in higher prevalence settings
had been longer.
The proportion of missed diagnoses was considerable.
Missed hepatitis B infection was especially prevalent
among Somali migrants, where half (8/16) of the HBsAg
findings had not been diagnosed previously. Among
Russian migrants, the majority of hepatitis B (3/5), hepa-
titis C (7/12), and syphilis (8/9) diagnoses had been
missed. Reasons for missed diagnosis include no screen-
ing on arrival and post-migration infections. A late diag-
nosis increases the morbidity and complications related
to a disease and may contribute to the spread of infec-
tions. Considering that 6–25% of the migrants from
hepatitis C endemic countries are estimated to be
viremic [17], the risk of further transmitting the infec-
tion is important.
Missed diagnosis was associated with factors that
could explain health behaviours or service use that in-
creases the risk for infection or missed diagnosis, i.e. not
living with a partner, perceived poor health, and smok-
ing. Similarly, as observed in the univariate analysis, pre-
vious abortion and alcohol use might be related to risky
sexual behaviour or addictions. Additionally, missed
diagnosis was associated with self-reported previous
diagnosis of a blood-borne infectious disease. Individuals
who reported a previous diagnosis, but for whom the
diagnosis had not been confirmed in Finland are beyond
the reach of the health care system, treatment, and pre-
ventive measures. Surprisingly, previous delivery was not
associated with a lower risk for missed diagnosis, even
though all pregnant women in Finland have been offered
screening for HIV (since 1998), hepatitis B (since 1994),
and syphilis (since the 1950s) and the up-take of ante-
natal screening is 98% [10]. However, the up-take and
coverage of antenatal screening has not been evaluated
among migrant populations [25]. Furthermore, we were
not able to distinguish births in Finland from those in
other countries.
Three out of four Somali migrants had arrived to
Finland as a refugee or an asylum seeker, and hence,
should have been offered a health check-up and infec-
tious disease screening upon arrival. Self-reported par-
ticipation in infectious disease screening upon
immigration did not influence the risk for missed diag-
nosis. More Kurdish and Somali migrants reported hav-
ing participated in infectious disease screening upon
arrival (85% and 81%, respectively) than had arrived to
the country as a refugee or an asylum seeker (73% and
72%, respectively). This over-reporting is explained by a
portion of the Kurdish and Somali migrants being
granted a residency permit due to a family reunion, and
hence, being offered a health check-up and screening
upon arrival. The findings imply a high coverage of in-
fectious disease screening among refugees and asylum
seekers in Finland. Acceptability of screening is a pre-
requisite for achieving a good screening coverage [26].
In this study, a high acceptability of HIV, hepatitis B and
C, and syphilis screening was achieved.
Originating from higher prevalence settings, such as
Russia, FSU, or Somalia, increases the pre-migratory risk
for infection, but the risk also remains elevated after mi-
gration. Post-migration infections might be acquired
within the destination country or while travelling to a
country with a higher disease prevalence or during cir-
culatory migration to the country of origin. Recent evi-
dence suggests an important proportion of post-
migration infections arise within the destination coun-
tries due to selective sexual mixing and individual risk
behaviours [3, 12]. Somali migrants in this study re-
ported relatively low levels of post-migration travelling
to the country of origin, which might suggest new infec-
tions within the migrant communities after migration.
Hepatitis B vaccine is currently included in the child-
hood vaccination programme in Somalia, but the vaccin-
ation coverage has remained modest (42% in 2016) [27].
Unvaccinated migrants from hepatitis B endemic areas
should be provided with a hepatitis B vaccine [28]. In
Finland, hepatitis B vaccine is recommended free of
charge to all individuals, including refugees and asylum
seekers, with an increased risk for infection [29]. How-
ever, the uptake of the vaccination has not been studied.
On the other hand, most Russian origin migrants re-
ported post-migration travelling to the country of origin.
Russia is considered an intermediate hepatitis C preva-
lence country (prevalence between 2.0% and 3.0%), but
the prevalence is likely to vary regionally [16].
Usage of health care services was frequent especially
among Kurdish and Russian women. Despite frequent
consultations, the majority of HBsAg, anti-HCV, and
anti-Trpa seropositive cases had been missed. Screening
of hepatitis C is not included in the screening guidelines
for asylum seekers and refugees in Finland [5], even
though evidence shows screening and treatment to be
cost-effective [30]. Consequently, the national hepatitis
C strategy recommends the screening of migrants from
high prevalence countries [31]. On the other hand, the
results depict the missing structured screening
programme to target non-refugee and non-asylum
seeker migrants in Finland. Assuming cost-effectiveness
for HBsAg screening at prevalence exceeding 1% [32],
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our results support the broadening of HBsAg screening
to Russian origin migrants in Finland. Health service
providers should not miss opportunities to offer infor-
mation and screening at health care contacts [33].
Limitations
The Maamu study included Kurdish, Russian, and So-
mali origin migrants, representing the main migrant
groups in Finland [8]. Since health behaviour and risk
factors differ significantly between different migrant
groups, the results from this study cannot be generalized
in allmigrantpopulations. Moreover, despite the popula-
tion based study design and adoption of population
weights in the analyses, additional sources of bias might
influence the reliability of the disease burden estimates.
A recent study has shown that Russian origin migrants
in Finland use cross-border parallel health care services
frequently [34]. Only seropositive findings made in
Finland are recorded in the NIDR, and hence, the num-
ber of missed diagnoses might be an over-estimation, es-
pecially among Russian migrants.
Syphilis diagnostics is challenging since a positive
syphilis serology (anti-Trpa) can result from either a pre-
viously treated infection or latent disease. One-third of
the missed diagnoses in the Maamu study had positive
syphilis serology (11/33), and six persons with a missed
syphilis serology had moved to Finland before 2005.
Prior to 2005, the Venereal Disease Research Laboratory
(VDRL) test was still commonly used for syphilis screen-
ing in Finland [10]. Since VDRL can be negative in latent
or previously treated disease, the proportion of missed
syphilis serology in this study might be an over-estimate.
Nevertheless, every positive syphilis serology finding
should be assessed thoroughly.
The quasi-complete separation observed in the multi-
variate regression model was due to low number of test-
positive cases (sparse data). The number of events per
variable was 4.25 which can be considered sufficient
without causing considerable relative bias or unreliable
CI coverage [35].
Conclusions
In the Maamu study, more than half of chronic hepatitis
B and C and syphilis diagnoses had been missed among
Kurdish, Russian, and Somali origin migrants in Finland
in spite of the national screening recommendations. The
prevalence of hepatitis B and C and syphilis was com-
parable or lower than in previous research among Kurd-
ish, Russian, or Somali origin migrants in high-income
countries. No cases of HIV were identified. Our results
suggest post-migration spread of hepatitis B among So-
mali migrants, which could be prevented by enhanced
screening and vaccinations. Russian migrants use health
services frequently, but are not tested, resulting in
missed opportunities to screen for hepatitis C and syph-
ilis. Missed diagnoses expose the migrants to complica-
tions, such as cirrhosis, hepatocellular carcinoma, or
tertiary syphilis, and may contribute to the continuous
spread of infections. The implementation and coverage
of current screening strategies among migrants should
be evaluated. Targeted hepatitis and syphilis screening
alongside prevention strategies should be implemented
among migrants upon arrival and in later health care
contacts.
Abbreviations
anti-HCV: Hepatitis C antibodies; anti-Trpa: Treponema pallidum antibodies;
CI: Confidence Interval; FSU: Former Soviet Union; HBsAg: Hepatitis B surface
antigen; HIV: Human Immunodeficiency Virus; HIVAgAb: HIV antigen and
antibodies; Maamu: Migrant population-based health interview and examin-
ation survey; NIDR: National Infectious Disease Register; OR: Odds Ratio;
PIC: Personal Identity Code; PIS: Population Information System;
VDRL: Venereal Disease Research Laboratory test
Acknowledgements
We would like to gratefully acknowledge all the study participants as well as
field-work personnel and researchers involved in planning and collecting
data for the Maamu study.
Funding
This study was funded by the National Institute for Health and Welfare of
Finland (Maamu study) and by the University of Helsinki, Doctoral
Programme for Population Health (PT).
Availability of data and materials
The data for this study are available from the National Institute for Health
and Welfare (THL), but some restrictions apply. The data were used under
license for the current study, and thus, are not publicly available. They are,
however, available from the authors upon reasonable request and with
permission of THL.
Authors’ contributions
The study was planned by PT, MR, KL, PKo, H-MS, EH-B, ID, and PKi. H-MS
was responsible for laboratory analyses. Data were collected and compiled
by the Maamu study team. Data were analysed by PT with assistance from
JO, MR, KL, and PKi. JO helped in performing the analyses and contributed
for the interpretation and discussion of the results. MR participated in the
planning of the study and has actively supported the data analysis, interpret-
ation of the results and reviewed the manuscript repeatedly. PT drafted the
manuscript with assistance from MR KL and PKi, which was critically reviewed
by all of the authors. All authors have read and approved the final manu-
script for publication.
Ethics approval and consent to participate
The Maamu study, including linkage to national registers, was evaluated and
endorsed by the coordinating Ethics Committee of the Helsinki and Uusimaa
Hospital District (325/13/03/00/2009). Written informed consent was
obtained from the participants separately for the health interview,
examination, and testing.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Tiittala et al. BMC Infectious Diseases  (2018) 18:137 Page 10 of 11
Author details
1Doctoral Programme in Population Health, University of Helsinki, Helsinki,
Finland. 2Department of Health Security, National Institute for Health and
Welfare, Mannerheimintie 166, 00271 Helsinki, Finland. 3Inflammation Center,
Helsinki University Hospital, Meilahdentie 2, 00250 Helsinki, Finland.
4Department of Public Health Solutions, National Institute for Health and
Welfare, Mannerheimintie 166, 00271 Helsinki, Finland. 5Oulu University
Hospital, Biobank Borealis of Northern Finland, Aapistie 5B, 90220 Oulu,
Finland.
Received: 6 November 2017 Accepted: 11 March 2018
References
1. European Centre for Disease Prevention and Control (ECDC): Assessing the
burden of key infectious diseases affecting migrant populations in the EU/
EEA. 2014.
2. Karki T, Napoli C, Riccardo F, Fabiani M, Dente MG, Carballo M, Noori T,
Declich S. Screening for infectious diseases among newly arrived migrants
in EU/EEA countries–varying practices but consensus on the utility of
screening. Int J Environ Res Public Health. 2014;11(10):11004–14.
3. Alvarez-Del Arco D, Fakoya I, Thomadakis C, Pantazis N, Touloumi G,
Gennotte AF, Zuure F, Barros H, Staehelin C, Gopel S, Boesecke C, Prestileo
T, Volny-Anne A, Burns F, Del Amo J, aMASE (advancing migrant access to
health Services in Europe) study team: high levels of post-migration HIV
acquisition within nine European countries. AIDS 2017 Sep 10, 31(14):1979–
1988.
4. Jaakola S, Lyytikäinen O, Huusko S, Salmenlinna S, Savolainen-Kopra C,
Liitsola K, Jalava J, Toropainen M, Nohynek H, Virtanen M, Löflund J, Kuusi
M, Salminen M. Tartuntataudit Suomessa 2016 [infectious diseases in
Finland in 2016]. National Institute for Health and Welfare (THL). 2017:5.
5. National Institute for Health and Welfare (THL). Pakolaisten ja
turvapaikanhakijoiden infektio-ongelmien ehkäisy [Prevention of infection
problems among refugees and asylum seekers]. Ministry for Social Affairs
and Health (STM). 2009:21.
6. Statistics Finland's PX-Web databases. Immigrants and integration statistics.
http://pxnet2.stat.fi/PXWeb/pxweb/en/?rxid=48fa4eee-fa22-4c7a-a539-
4948464d0637. Accessed 31 August 2017.
7. National Institute for Health and Welfare (THL). Countries with a high
incidence of tuberculosis as well as diseases screened for among refugees
and asylum seekers by country. In: THL; 2015.
8. National Institute for Health and Welfare (THL). Maahanmuuttajien terveys ja
hyvinvointi. Tutkimus venäläis-, somalialais- ja kurditaustaisista Suomessa
[Migrant health and wellbeing. A study on persons of Russian, Somali and
Kurdish origin in Finland]. THL. 2012:61.
9. Rask S, Suvisaari J, Koskinen S, Koponen P, Molsa M, Lehtisalo R, Schubert C,
Pakaslahti A, Castaneda AE. The ethnic gap in mental health: a population-
based study of Russian, Somali and Kurdish origin migrants in Finland.
Scand J Public Health. 2016;44(3):281–90.
10. Surcel H, Haula T, Mäkelä M, Aho I, Hiltunen-Back E, Salo E, Isojärvi J, Backas
J, Leipälä J. Alkuraskauden infektioseulonta Suomessa [infection screening in
early pregnancy in Finland]. National Institute for Health and Welfare (THL).
2014;7
11. Robins J, Rotnitzky A, Zhao L. Estimation of regression coefficients when
some Regressors are not always observed. J Am Stat Assoc. 1994;89(427):
846–66.
12. Loos J, Nostlinger C, Vuylsteke B, Deblonde J, Ndungu M, Kint I,
Manirankunda L, Reyniers T, Adobea D, Laga M, Colebunders R. First HIV
prevalence estimates of a representative sample of adult sub-Saharan
African migrants in a European city. Results of a community-based, cross-
sectional study in Antwerp, Belgium. PLoS One. 2017;12(4):e0174677.
13. Padovese V, Egidi A, Melillo T, Farrugia B, Carabot P, Didero D, Costanzo G,
Mirisola C. Prevalence of latent tuberculosis, syphilis, hepatitis B and C
among asylum seekers in Malta. J Public Health (Oxf). 2014;36(1):22–7.
14. Giorgi Rossi P, Riccardo F, Pezzarossi A, Ballotari P, Dente MG, Napoli C,
Chiarenza A, Velasco Munoz C, Noori T, Declich S. Factors influencing the
accuracy of infectious disease reporting in migrants: a scoping review. Int J
Environ Res Public Health. 2017;14(7)
15. Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer
G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and
prior immunity in immigrants and refugees: a systematic review and meta-
analysis. PLoS One. 2012;7(9):e44611.
16. Greenaway C, Thu Ma A, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I.
The Seroprevalence of hepatitis C antibodies in immigrants and refugees
from intermediate and high endemic countries: a systematic review and
meta-analysis. PLoS One. 2015;10(11):e0141715.
17. European Centre for Disease Prevention and Control (ECDC).
Epidemiological assessment of hepatitis B and C among migrants in the
EU/EEA. In: ECDC; 2016.
18. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of
chronic hepatitis B among foreign-born persons living in the United States
by country of origin. Hepatology. 2012;56(2):422–33.
19. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology
and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;
61(1 Suppl):S45–57.
20. Chaabna K, Kouyoumjian SP, Abu-Raddad LJ: Hepatitis C Virus Epidemiology
in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-
Analysis. PLoS One 2016, 11(2):e0149966 LID.
21. Hernando V, Alvarez-del Arco D, Alejos B, Monge S, Amato-Gauci A,J., Noori
T, Pharris A, del Amo J: HIV infection in migrant populations in the
European Union and European economic area in 2007-2012: an epidemic
on the move. J Acquir Immune Defic Syndr 2015, 70(2):204.
22. UNAIDS. HIV estimated with uncertainty bounds 1990–2016. http://www.
unaids.org/en/resources/documents/2017/HIV_estimates_with_uncertainty_
bounds_1990-2016. Accessed 31 August 2017.
23. Bailey H, Turkova A, Thorne C, Syphilis h C, in Eastern Europe HIV. Curr Opin
Infect Dis. 2017;30(1):93.
24. Regional UNAIDS. Factsheets. Eastern Europe and central. Asia. 2016; http://
www.unaids.org/en/regionscountries/easterneuropeandcentralasia. Accessed
02 February 2018
25. European Centre for Disease Prevention and Control [ECDC]. Technical
report. Antenatal screening for HIV, hepatitis B, syphilis and rubella
susceptibility in the EU/EEA. In: ECDC; 2016.
26. Tiittala P, Kivelä P, Ristola M, Surcel H, Koponen P, Mölsä M, Ollgren J,
Liitsola K. Achieving high acceptability of HIV testing in a population-based
survey among immigrants in Finland. Scand J Public Health. 2015;43(4):393–
8.
27. World Health Organization (WHO). Vaccine-preventable diseases: monitoring
system. 2017 global summary. http://apps.who.int/immunization_
monitoring/globalsummary. Accessed 15th September 2017.
28. Mipatrini D, Stefanelli P, Severoni S, Rezza G. Vaccinations in migrants and
refugees: a challenge for European health systems. A systematic review of
current scientific evidence. Pathog Glob Health. 2017;111(2):59–68.
29. National Institute for Health and Welfare (THL). Vaccinations for children and
adolescents in at-risk groups. https://www.thl.fi/en/web/vaccination/
national-vaccination-programme/vaccination-programme-for-children-and-
adolescents/vaccinations-for-children-and-adolescents-in-at-risk-groups.
Accessed 02 February 2018.
30. Coretti S, Romano F, Orlando V, Codella P, Prete S, Di Brino E, Ruggeri M.
Economic evaluation of screening programs for hepatitis C virus infection:
evidence from literature. Risk Manag Healthc Policy. 2015;8:45–54.
31. Ministry for Social Affairs and Health (STM). Suomen C-hepatiittistrategia
2017-2019 [Finland's hepatitis C strategy 2017-2019]. STM. 2016;63:15.
32. Veldhuijzen IK, Toy M, Hahne S, De Wit G, Schalm S, de Man R, Richardus
JH. Screening and early treatment of migrants for chronic hepatitis B virus
infection is cost-effective. Gastroenterology. 2010;138(2):522–30.
33. Cochrane A, Collins P, Horwood JP. Barriers and opportunities for hepatitis B
testing and contact tracing in a UK Somali population: a qualitative study.
Eur J Pub Health. 2016;26(3):389–95.
34. Kemppainen L, Kemppainen T, Skogberg N, Kuusio H, Koponen P.
Immigrants' use of health care in their country of origin: the role of social
integration, discrimination and the parallel use of health care systems.
Scand J Caring Sci. 2017, Sep 4; [Epub ahead of print]
35. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in
logistic and cox regression. Am J Epidemiol. 2007;165(6):710–8.
Tiittala et al. BMC Infectious Diseases  (2018) 18:137 Page 11 of 11
